Advertisement
In a video interview on financial broadcaster http://www.cantos.com,Group CEO Said Darwazah re-committed to his target of doubling the size ofthe business every four years, saying, "If you look at our track record overthe last 10 or 12 years you see that we've pretty much delivered that and Isee no reason why we won't be able to continue delivering that. So mycommitment stands."
Advertisement
The emerging markets-based Pharma company also reported a return toprofitability in its US generics business and improving trends in itsEuropean Injectables and Oncology businesses
Hikma also has a $300m dollar war chest for acquisitions. Group ChiefFinancial Officer, Bassam Kanaan, said: "We have up to about $300m ofborrowing capacity which we can use to fund acquisitions that we plan tomake, especially in the MENA region. Anything above that, I think we willhave to explore other options for funding."
The interviews and transcripts are available now on http://www.cantos.com.
Cantos.com, the online financial broadcaster, features in-depthinterviews, documentaries and webcasts with senior company executives. If youwould like to contact us, please email [email protected] or phone+44-207-936-1352.
SOURCE Hikma Pharmaceuticals
